Statera Biopharma, Inc. (STAB)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Aug 19, 2026, 4:00 PM EST
Statera Biopharma Revenue
Statera Biopharma had revenue of $670.47K in the quarter ending September 30, 2022, with 183.48% growth. This brings the company's revenue in the last twelve months to $3.69M, up 1,459.14% year-over-year. In the year 2021, Statera Biopharma had annual revenue of $1.49M.
Revenue (ttm)
3.69M
Revenue Growth
+1,459.14%
P/S Ratio
0.00
Revenue / Employee
80.17K
Employees
46
Market Cap
7.26K
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2021 | 1.49M | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Statera Biopharma News
- 1 year ago - Tivic Health receives two investigational new drug applications from Statera - TheFly
- 1 year ago - Tivic Health acquires exclusive rights to Entolimod from Statera BioPharma - TheFly
- 1 year ago - Tivic Health Acquires Exclusive Worldwide Rights to Phase III TLR5 Agonist from Statera Biopharma - Business Wire
- 3 years ago - Statera BioPharma, Biostax reach dispute settlement, amended license agreement - TheFly
- 3 years ago - Statera BioPharma enters LOI for merger with Worksite Labs - TheFly
- 3 years ago - Statera Biopharma Signs Letter of Intent for Merger with Worksite Labs - GlobeNewsWire
- 3 years ago - Statera Biopharma Announces Completion of Application Process to Uplist to the OTCQB(R) Venture Marketplace - Accesswire
- 4 years ago - Statera Biopharma Receives Positive Nasdaq Listing Determination - Accesswire